People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...
Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.
The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to ...
The FDA issued an alert warning diabetes patients and caregivers about potential issues with smartphone alerts for continuous ...